ECG EBITDA Growth
53.18%TTM
Period ending:
ECG TTM EBITDA YoY %%
60.63%-16.30%
2024-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
ECG ebitda growth history
Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 7 observations from Dec 31, 2024 to Jun 30, 2026.
| Period ending | EBITDA Growth |
|---|---|
| 53.1836% | |
| 48.5226% | |
| 43.3453% | |
| 20.2045% | |
| 9.8375% | |
| -0.5797% | |
| -8.8571% |
Compare ebitda growth
All ECG financial metrics · ECG stock overview · How to interpret financial metrics
